Characterization of extracellular and membrane potentials in imeglimin‐treated islets

Documenti analoghi

• Gastrointestinal symptoms in patients receiving imeglimin in combination with metformin: A post‐hoc analysis of imeglimin clinical trial data
  di: Jumpei Ito, et al.
  Pubblicazione: (2024)
• Urinary extracellular vesicle miRNA signature reflects pancreatic islet stress in type 2 diabetes
  di: Md. Zubbair Malik, et al.
  Pubblicazione: (2026)
• Gαs defines the fundamental coupling mechanism of insulin secretion
  di: Jun Shirakawa
  Pubblicazione: (2025)
• Commentary on “Intra‐islet α‐cell Gs signaling promotes glucagon release”
  di: Tadahiro Kitamura
  Pubblicazione: (2024)
• Long‐term safety and efficacy of imeglimin in Japanese individuals with type 2 diabetes and chronic kidney disease: A 52‐week postmarketing clinical study ( TWINKLE )
  di: Tetsuya Babazono, et al.
  Pubblicazione: (2025)